Press releases
- Masimo to Present in BofA Securities Health Care Conference
- Masimo Reports First Quarter 2024 Financial Results
- Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
- Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7
- Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
- Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
- Politan Nominates Two Independent Candidates for Masimo Board
- Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
- Masimo Named One of Fast Company’s Most Innovative Companies in North America
- Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
More ▼
Key statistics
On Friday, Masimo Corp (0JZ2:LSE) closed at 121.95, 61.84% above the 52 week low of 75.35 set on Oct 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 121.95 |
Average volume | 96.67 |
---|---|
Shares outstanding | 52.91m |
Free float | 48.85m |
P/E (TTM) | 83.16 |
Market cap | 6.44bn USD |
EPS (TTM) | 1.46 USD |
Data delayed at least 20 minutes, as of May 10 2024 16:21 BST.
More ▼